Europe Active Pharmaceutical Ingredients (API) Market 2022-2032

Table of Content

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18

2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32
2.2 Major Growth Drivers 36
2.3 Market Restraints and Challenges 44
2.4 Emerging Opportunities and Market Trends 47
2.5 Porter’s Fiver Forces Analysis 51

3 Segmentation of Europe Market by Molecule 55
3.1 Market Overview by Molecule 55
3.2 Small Molecule APIs 57
3.3 Large Molecule APIs 58

4 Segmentation of Europe Market by Synthesis 59
4.1 Market Overview by Synthesis 59
4.2 Synthetic API 61
4.2.1 Branded Synthetic API 62
4.2.2 Generic Synthetic API 63
4.3 Biotech API 64
4.3.1 Biotech API by Drug Type 65
4.3.1.1 Monoclonal Antibodies 66
4.3.1.2 Recombinant Proteins 67
4.3.1.3 Vaccines 68
4.3.1.4 Other Biotech APIs 69
4.3.2 Biotech API by Category 70
4.3.2.1 Innovative Biologic API 71
4.3.2.2 Generic Biosimilar API 72
4.3.3 Biotech API by Expression Technology 73
4.3.3.1 Mammalian Expression 74
4.3.3.2 Microbial Expression 75
4.3.3.3 Yeast Expression 76
4.3.3.4 Insect Expression 77
4.3.3.5 Other Expression Technologies 78
4.4 HPAPI 79
4.4.1 Branded HPAPI 80
4.4.2 Generic HPAPI 81

5 Segmentation of Europe Market by Manufacturing Process 82
5.1 Market Overview by Manufacturing Process 82
5.2 Captive Manufacturing 84
5.2.1 Branded Captive API 85
5.2.2 Generic Captive API 86
5.3 Merchant Manufacturing 87
5.3.1 Merchant Manufacturing by Drug Type 88
5.3.1.1 Branded Merchant API 89
5.3.1.2 Generic Merchant API 90
5.3.2 Merchant Manufacturing by Drug Synthesis 91
5.3.2.1 Merchant Synthetic API 92
5.3.2.2 Merchant Biotech API 93

6 Segmentation of Europe Market by Therapeutic Application 94
6.1 Market Overview by Therapeutic Application 94
6.2 Infectious Diseases 96
6.3 Oncology 97
6.4 Ophthalmology 98
6.5 Cardiovascular Disorders 99
6.6 Central Nervous System 100
6.7 Pulmonary Disorders 101
6.8 Orthopedics 102
6.9 Other Applications 103

7 Segmentation of Europe Market by Drug Type 104
7.1 Market Overview by Drug Type 104
7.2 Branded Prescription Drugs 106
7.3 Generic Prescription Drugs 107
7.4 OTC Drugs 108

8 European Market 2022-2032 by Country 109
8.1 Overview of European Market 109
8.2 UK 112
8.3 France 114
8.4 Germany 116
8.5 Spain 119
8.6 Italy 121
8.7 Russia 123
8.8 Rest of European Market 125

9 Competitive Landscape 127
9.1 Overview of Key Vendors 127
9.2 New Product Launch, Partnership, Investment, and M&A 130
9.3 Company Profiles 131
AbbVie Inc. 131
Astrazeneca 133
Aurobindo Pharma Ltd. 138
BASF 141
Bayer AG 144
Boehringer Ingelheim 148
Catalent Inc. 153
Dr. Reddy’s Laboratories 156
F. Hoffmann-La Roche 158
GlaxoSmithKline plc 161
Lonza Group 166
Lupin Limited 170
Merck & Co., Inc. 173
Mylan NV 176
Novartis International AG 179
Pfizer Inc. 182
Sanofi 187
Sun Pharmaceutical Industries Ltd. 190
Teva Pharmaceutical Industries Ltd. 193
Thermo Fisher Scientific 195
Related Reports and Products 198

List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. Europe Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 36
Figure 7. GDP per capita in the World, 1960-2022, $ thousand 39
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 40
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 41
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 41
Figure 11. Primary Restraints and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 44
Figure 12. Investment Opportunity Analysis 48
Figure 13. Porter’s Fiver Forces Analysis of Europe Active Pharmaceutical Ingredients (API) Market 51
Figure 14. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue 56
Figure 15. Europe Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%) 56
Figure 16. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn 57
Figure 17. Europe Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn 58
Figure 18. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue 59
Figure 19. Contribution to Europe 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 60
Figure 20. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn 61
Figure 21. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn 62
Figure 22. Europe Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn 63
Figure 23. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn 64
Figure 24. Europe Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn 66
Figure 25. Europe Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn 67
Figure 26. Europe Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn 68
Figure 27. Europe Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn 69
Figure 28. Europe Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn 71
Figure 29. Europe Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn 72
Figure 30. Europe Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn 74
Figure 31. Europe Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn 75
Figure 32. Europe Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn 76
Figure 33. Europe Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn 77
Figure 34. Europe Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn 78
Figure 35. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn 79
Figure 36. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn 80
Figure 37. Europe Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn 81
Figure 38. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue 82
Figure 39. Contribution to Europe 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 83
Figure 40. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn 84
Figure 41. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn 85
Figure 42. Europe Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn 86
Figure 43. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn 87
Figure 44. Europe API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn 89
Figure 45. Europe API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn 90
Figure 46. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn 92
Figure 47. Europe API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn 93
Figure 48. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue 94
Figure 49. Contribution to Europe 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 95
Figure 50. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn 96
Figure 51. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn 97
Figure 52. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn 98
Figure 53. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn 99
Figure 54. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn 100
Figure 55. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn 101
Figure 56. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn 102
Figure 57. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn 103
Figure 58. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue 104
Figure 59. Contribution to Europe 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 105
Figure 60. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn 106
Figure 61. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn 107
Figure 62. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn 108
Figure 63. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue 110
Figure 64. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%) 111
Figure 65. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn 112
Figure 66. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn 114
Figure 67. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn 116
Figure 68. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn 119
Figure 69. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn 121
Figure 70. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn 123
Figure 71. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn 125
Figure 72. Growth Stage of Europe Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 127
Figure 73. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022 134
Figure 74. AstraZeneca: Breakdown of Revenue by Region, 2022 134
Figure 75. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022 149
Figure 76. Boehringer Ingelheim: R&D Investement, 2019-2022 150

List of Tables

List of Tables:

Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 33
Table 5. World Health Spending by Region, $ bn, 2013-2020 42
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 43
Table 7. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 47
Table 8. Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 55
Table 9. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 59
Table 10. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 61
Table 11. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 65
Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 70
Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 73
Table 14. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 79
Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 82
Table 16. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 84
Table 17. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 88
Table 18. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 91
Table 19. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 94
Table 20. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 104
Table 21. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 111
Table 22. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 113
Table 23. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 113
Table 24. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 113
Table 25. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 115
Table 26. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 115
Table 27. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 115
Table 28. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 117
Table 29. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 117
Table 30. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 117
Table 31. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 120
Table 32. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 120
Table 33. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 120
Table 34. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122
Table 35. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122
Table 36. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122
Table 37. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 124
Table 38. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 124
Table 39. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 124
Table 40. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn 126
Table 41. AbbVie Inc.: Company Snapshot 131
Table 42. AbbVie Inc.: Business Segmentation 132
Table 43. AbbVie Inc.: Product Portfolio 132
Table 44. Astrazeneca: Company Snapshot 133
Table 45. Aurobindo Pharma Ltd.: Company Snapshot 138
Table 46. Aurobindo Pharma Ltd.: Product Portfolio 139
Table 47. BASF: Company Snapshot 141
Table 48. BASF: Business Segmentation 142
Table 49. Bayer AG: Company Snapshot 144
Table 50. Bayer AG: Business Segmentation 145
Table 51. Bayer AG: Product Portfolio 145
Table 52. Boehringer Ingelheim: Company Snapshot 148
Table 53. Boehringer Ingelheim: Product Portfolio 149
Table 54. Catalent Inc.: Company Snapshot 153
Table 55. Catalent Inc.: Business Segmentation 154
Table 56. Catalent Inc.: Product Portfolio 154
Table 57. Dr. Reddy’s Laboratories: Company Snapshot 156
Table 58. Dr. Reddy’s Laboratories: Business Segmentation 156
Table 59. F. Hoffmann-La Roche: Company Snapshot 158
Table 60. F. Hoffmann-La Roche: Clinical Trial Service 158
Table 61. F. Hoffmann-La Roche: Business Segmentation 159
Table 62. F. Hoffmann-La Roche: Revenue by Region 159
Table 63. GlaxoSmithKline: Company Snapshot 161
Table 64. GlaxoSmithKline: Business Segmentation 162
Table 65. GlaxoSmithKline: Product Portfolio 163
Table 66. Lonza Group: Company Snapshot 166
Table 67. Lonza Group: Business Segmentation 167
Table 68. Lonza Group: Product Portfolio 167
Table 69. Lupin Limited: Company Snapshot 170
Table 70. Lupin Limited: Business Segmentation 171
Table 71. Merck & Co., Inc.: Company Snapshot 173
Table 72. Merck & Co., Inc.: Business Segmentation 174
Table 73. Mylan NV: Company Snapshot 176
Table 74. Mylan NV: Breakdown of Revenue by Region, 2022 177
Table 75. Mylan NV: Breakdown of Revenue by Product Category, 2022 177
Table 76. Novartis International AG: Company Snapshot 179
Table 77. Novartis International AG: Business Segmentation 180
Table 78. Pfizer Inc.: Company Snapshot 182
Table 79. Pfizer Inc.: Business Segmentation 183
Table 80. Pfizer Inc.: Breakdown of Revenue by Product Category 183
Table 81. Pfizer Inc.: Breakdown of Revenue by Region 184
Table 82. Pfizer Inc.: Product Portfolio 184
Table 83. Sanofi: Company Snapshot 187
Table 84. Sanofi: Business Segmentation 188
Table 85. Sanofi: Breakdown of Revenue by Region 188
Table 86. Sun Pharmaceutical Industries Limited: Company Snapshot 190
Table 87. Teva Pharmaceutical Industries Ltd.: Company Snapshot 193
Table 88. Teva Pharmaceutical Industries Ltd.: Business Segmentation 194
Table 89. Thermo Fisher Scientific: Company Snapshot 195
Table 90. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, % 196
Table 91. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, % 196